Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial Results
08 juil. 2019 16h03 HE
|
Sonoma Pharmaceuticals, Inc.
Strong Annual Year-Over-Year Growth with 14% Revenue Growth Strong Quarter-Over-Quarter Growth with 20% Revenue Growth and 25% Reduction in Expenses Reduction in Annual Year-Over-Year Net Loss by...
Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common Stock
19 juin 2019 16h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced the timing for a 1-for-9 reverse split of its...
Sonoma Pharmaceuticals Sells Animal Health Rights in Asia and Europe for $2.7 million
21 mai 2019 16h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced the sale of certain animal health product rights and...
Sonoma Pharmaceuticals Announces Substantial Cost-Cutting Measures
12 mars 2019 18h30 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced substantial cost-cutting measures, including...
Sonoma Pharmaceuticals Announces Management Changes
14 déc. 2018 17h30 HE
|
Sonoma Pharmaceuticals, Inc.
CEO Jim Schutz and CFO Robert Miller Step DownFrederick (Bubba) Sandford Appointed as New CEO and Interim CFO and will Join the Board PETALUMA, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- Sonoma...
Sonoma Pharmaceuticals Announces Pricing of Public Offering of Units
17 nov. 2018 11h01 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., Nov. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of a “best efforts” public offering of units consisting of one share of...
Sonoma Pharmaceuticals Reports Record Revenue in Second Quarter FY 2019
08 nov. 2018 16h03 HE
|
Sonoma Pharmaceuticals, Inc.
• Total Revenue of $4.9 Million, up 13% over June 2018 Quarter• Total Revenue up 14% over September 2017 Quarter Conference Call Begins at 4:30 pm EST Today PETALUMA, Calif., Nov. 08, 2018 (GLOBE...
Sonoma Pharmaceuticals Announces Second Quarter FY 2019 Financial Results and Conference Call
01 nov. 2018 07h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced that financial results for its fiscal year 2019 second quarter, ended September 30,...
Sonoma Pharmaceuticals Announces Newly Published Results from Study of Hypochlorous Acid in Management of Hypertrophic and Keloid Scars
25 oct. 2018 07h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced newly published results from a study into the use of the company’s proprietary...
Sonoma Pharmaceuticals Launches New Ceramax™ Skin Barrier Lotion with Skin-Enriching Lipogrid Technology™
17 oct. 2018 07h05 HE
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company that develops and markets unique and effective solutions for the...